Researchers identify gene that leads to myopia (nearsightedness)

September 1, 2011

A Ben-Gurion University of the Negev research group led by Prof. Ohad Birk has identified a gene whose defect specifically causes myopia or nearsightedness.

In an article appearing online in the today, Birk and his team reveal that a mutation in LEPREL1 has been shown to cause myopia.

"We are finally beginning to understand at a molecular level why occurs," Prof. Birk says. The discovery was a group effort at BGU's Morris Kahn Laboratory of Human Genetics at the National Institute for Biotechnology in the Negev and the Dayan Wing at Soroka University Medical Center.

Nearsightedness is the most common human eye disorder and is mostly a hereditary trait. Aside from being a significant public health concern, nearsightedness also leads to a higher incidence of other secondary eye disorders, such as , macular degeneration, as well as early onset glaucoma and cataracts. Despite decades of intensive research, the specific genes whose defects lead to nearsightedness have remained elusive.

The defective gene was identified in a thorough study of severe early-onset myopia that is common in a specific Bedouin tribe in southern Israel. As part of the research and in collaboration with a Finnish group, studies in a model system using demonstrated that the mutation is detrimental to the enzymatic activity of the gene.

The gene, LEPREL1, encodes an enzyme that is essential for the final modification of collagen in the eye. In the absence of the active form of this enzyme, aberrant collagen is formed, causing the human eyeball to be longer than normal. As a consequence, entering the eyeball focus in front of the retina rather than on the retina itself and myopia emerges.

Future studies will determine whether LEPREL1 or its related genes play a significant role in the causation of myopia in the population at large as well.

Prof. Birk's group has thus far elucidated the molecular mechanisms leading to more than 15 human diseases, and the research findings are effectively implemented in massive screening tests and prevention programs.

Related Stories

Recommended for you

New class of RNA tumor suppressors identified

November 23, 2015

A pair of RNA molecules originally thought to be no more than cellular housekeepers are deleted in over a quarter of common human cancers, according to researchers at the Stanford University School of Medicine. Breast cancer ...

Batten disease may benefit from gene therapy

November 11, 2015

In a study of dogs, scientists showed that a new way to deliver replacement genes may be effective at slowing the development of childhood Batten disease, a rare and fatal neurological disorder. The key may be to inject viruses ...

Molecular clocks control mutation rate in human cells

November 9, 2015

Every cell in the human body contains a copy of the human genome. Through the course of a lifetime all cells are thought to acquire mutations in their genomes. Some of the mutational processes generating these mutations do ...


Adjust slider to filter visible comments by rank

Display comments: newest first

not rated yet Sep 02, 2011
This research extends on a foundation pioneered in the following reference link:

A final modification of collagen is incorrect. The process of modification is reversible. During embryonic development eyes are formed or shaped. Forming or shaping can only occur before LEPREL1 encodes an enzyme(which?) for modification of collagen. There is nothing "final" about a reversible modification.
not rated yet Sep 02, 2011

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.